Artificial Intelligence in Assessing Progression of Age-Related Macular Degeneration

Published

2024

Audience

Therapeutic Area

Content Type

AI Generated Summary*

A narrative review surveys machine and deep learning tools for tracking and forecasting age-related macular degeneration progression at all disease stages, from literature searched December 2023 to March 2024. Examples span OCT quantification of drusen, outer retinal layers and hyperreflective foci; a fellow-eye model with AUCs of 0.68 for neovascular conversion and 0.80 for atrophy; atrophy segmentation on autofluorescence and infrared images with dice coefficients from about 0.89 upward, mostly lacking external validation; and fluid quantification validated across 11,127 eyes. Post-hoc trial analyses tie intraretinal fluid to poorer acuity, while genetic data added little to one prognostic model. Noted constraints include dataset diversity, interpretability, image quality, privacy and cost, with validated algorithms framed as easing rising monitoring demands.

*This summary was generated by AI and is published unedited. Oku does not alter these summaries. It may contain errors or omissions and is provided for general informational purposes only. Oku does not guarantee its accuracy, completeness, or reliability. For authoritative information, please refer to the original, peer-reviewed article.

At a glance

Authors
Sophie Frank-Publig; Klaudia Birner; Sophie Riedl; Gregor S. Reiter; Ursula Schmidt-Erfurth
Publication
Eye
Keywords
Artificial Intelligence, Disease Progression, Macular Degeneration, Algorithms, Tomography, Optical Coherence Tomography
Year
2024
View primary source

This is the evidence

See where we take it next

Join the Network